Biohaven appoints director
Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet
Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback
Infographic: The Big Picture 2023 Sustainability Outlook
The Big Picture for 2023: Assessing Investment Trends and the Impact of Investor Activism
Biohaven Pharmaceutical Holding Co. Ltd. appointed Julia Gregory to the company's board of directors, taking its membership to seven.
Gregory was formerly the president and CEO of Five Prime Therapeutics Inc.
